Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

90% Don't Know When New Health Insurance Exchanges Open

SAN FRANCISCO, April 4, 2013 -- Ninety percent of Americans don't know when the new health insurance exchanges will open, according to a new survey released today by InsuranceQuotes.com.

National Cancer Organizations Issue Joint Statement On Devastating Impact Of Sequestration

WASHINGTON, April 3, 2013 -- The Community Oncology Alliance (COA), in conjunction with the American Society of Clinical Oncology (ASCO), International Oncology Network/AmerisourceBergen, and the US Oncology Network, issued a joint statement on the crippling effects of sequestration cuts to cancer drugs and services which began April 1, 2013.  The organizations also sent letters to Health and Human Services (HHS), the United States Senate and the United States House of Representatives.  Sequestration cuts will apply not only to services physicians and others provide, but also to the fixed, pass-through costs of chemotherapy and related cancer-fighting drugs.  Community cancer care providers are struggling to survive in this unsustainable environment.

CMS: Proposed rule outlines Navigator standards for HIX

The Centers for Medicare & Medicaid Services (CMS) released a proposed rule outlining standards that Navigators in federally-facilitated and state partnership marketplaces must meet, clarifying earlier guidance about the Navigator program.

Ohio's 6th Annual Healthcare Information Technology Day Highlights the Importance of HIT for Ohio Legislators

Columbua, Ohio, April 3, 2013 -- The connection between Ohio's economic future and Technology in Healthcare will be the focus of discussions with legislators at the Ohio Statehouse by advocates of Healthcare Information Technology (HIT) on April 11.

N.C. bill requires providers to disclose costs via state HIE

Legislation introduced March 27 by North Carolina state senators Bob Rucho and Harry Brown seeks a number of measures to improve transparency in healthcare costs provided by hospitals and ambulatory surgical facilities.

Healthbox Kicks Off Second Boston Accelerator Program with Lead Partner Blue Cross Blue Shield of Massachusetts

April 2, 2013 -- Healthbox, a leading business accelerator that supports early-stage health care companies, kicked off its second program today in Kendall Square. After completing the inaugural Boston program in November 2012, Healthbox and anchor partner Blue Cross Blue Shield of Massachusetts (BCBSMA), quickly launched a second program dedicated to supporting innovative start-up companies to respond to continued industry demand for creative solutions to pervasive healthcare challenges.

Legislation would lessen regulatory burden for certain providers

Rep. Diana Black (R-Tenn.) introduced legislation on March 21 to amend the HITECH Act to decrease regulatory burden for certain providers struggling to meet Meaningful Use requirements.

Legislator presses OIG to extend EHR safe harbor provision

With the EHR safe harbor provision set to expire at the end of 2013, one lawmaker is urging the Department of Health and Human Services' Office of Inspector General (OIG) to take action to renew the arrangement that allows the donation of EHR technology and electronic prescribing under certain instances.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.